Jounce Therapeutics Inc buy Slaandjivaa
Start price
14.03.17
/
50%
€19.65
Target price
24.03.17
€25.26
Performance (%)
17.43%
End price
24.03.17
€23.07
Summary
This prediction ended on 24.03.17 with a price of €23.07. The prediction had a final performance of 17.43%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Jounce Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by Slaandjivaa for this prediction
In the thread Jounce Therapeutics Inc diskutieren
Unschlaff
Achten:
http://seekingalpha.com/article/4054590-buy-shares-lesser-known-celgene-partner
(Vom Mitglied beendet)


